These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Toxoplasmosis prevention knowledge among pregnant women in Minnesota. Ogunmodede F; Scheftel J; Jones JL; Lynfield R Minn Med; 2005 Feb; 88(2):32-4. PubMed ID: 17886796 [TBL] [Abstract][Full Text] [Related]
43. Factors affecting the adherence to an antenatal screening programme: an experience with toxoplasmosis screening in France. Cornu C; Bissery A; Malbos C; Garwig R; Cocherel C; Ecochard R; Peyron F; Wallon M Euro Surveill; 2009 Mar; 14(9):21-5. PubMed ID: 19317970 [TBL] [Abstract][Full Text] [Related]
44. Twenty-two years screening for toxoplasmosis in pregnancy: Liege-Belgium. Henri T; Jacques S; Rene L Scand J Infect Dis Suppl; 1992; 84():84-5. PubMed ID: 1290082 [TBL] [Abstract][Full Text] [Related]
45. [Toxoplasmosis in pregnancy. Prevention, diagnosis, and therapy]. Russo M Recenti Prog Med; 1994 Jan; 85(1):37-48. PubMed ID: 8184179 [TBL] [Abstract][Full Text] [Related]
46. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Pappas G; Roussos N; Falagas ME Int J Parasitol; 2009 Oct; 39(12):1385-94. PubMed ID: 19433092 [TBL] [Abstract][Full Text] [Related]
47. [Toxoplasmosis screening: tu felix Austria?]. Seitz HM Wien Klin Wochenschr; 1997 Sep; 109(16):621-2. PubMed ID: 9412083 [No Abstract] [Full Text] [Related]
48. [Congenital toxoplasmosis in own studies]. Kmieć K; Woźniakowska-Gesicka T; Andrzejewski A Wiad Parazytol; 2001; 47 Suppl 1():51-7. PubMed ID: 16897952 [TBL] [Abstract][Full Text] [Related]
49. Screening programme for congenital toxoplasmosis in France. Thulliez P Scand J Infect Dis Suppl; 1992; 84():43-5. PubMed ID: 1290073 [TBL] [Abstract][Full Text] [Related]
50. Toxoplasmosis: a preventable cause of brain damage. Gordon N Dev Med Child Neurol; 1993 Jul; 35(7):567-73. PubMed ID: 9435772 [No Abstract] [Full Text] [Related]
52. Toxoplasmosis. Pope E Midwives Chron; 1992 Oct; 105(1257):300-3. PubMed ID: 1305941 [No Abstract] [Full Text] [Related]
53. [Diagnosis and therapy of congenital toxoplasmosis]. Friese K; Weigel M; Melchert F Dtsch Med Wochenschr; 1993 Dec; 118(49):1814-6. PubMed ID: 8253045 [No Abstract] [Full Text] [Related]
54. Choices in preventive strategies: experience with the prevention of congenital toxoplasmosis in The Netherlands. Conyn-van Spaedonck MA; van Knapen F Scand J Infect Dis Suppl; 1992; 84():51-8. PubMed ID: 1290075 [TBL] [Abstract][Full Text] [Related]
56. Neonatal screening for congenital toxoplasmosis in Denmark: presentation of the design of a prospective study. Lebech M; Petersen E Scand J Infect Dis Suppl; 1992; 84():75-9. PubMed ID: 1290080 [TBL] [Abstract][Full Text] [Related]
57. Contribution of new techniques for the diagnosis of congenital toxoplasmosis. Robert-Gangneux F Clin Lab; 2001; 47(3-4):135-41. PubMed ID: 11294576 [TBL] [Abstract][Full Text] [Related]
58. Economic evaluation of preventive programmes against congenital toxoplasmosis. Stray-Pedersen B; Jenum P Scand J Infect Dis Suppl; 1992; 84():86-96. PubMed ID: 1290083 [TBL] [Abstract][Full Text] [Related]
60. Increasing toxoplasma seropositivity in women with bad obstetric history and in newborns. Sharma P; Gupta I; Ganguly NK; Mahajan RC; Malla N Natl Med J India; 1997; 10(2):65-6. PubMed ID: 9153982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]